Skip to content
Clinical Trial Events
BIO-Europe 2026

Talk Presenting Companies (Theatre A) track

Immunology: CAGE Bio Inc.

Mon, Nov 9, 2026 · 3:15–3:30 PM CET Koelnmesse

About this session

CAGE Bio is advancing novel therapies for localized treatment of immunological skin diseases. Powered by the proprietary ionic liquid platform, CAGE Bio is advancing small and large molecules including oliognucleotides that are delivered non-invasively into the skin for maximum effect site bioavailability.

Speaker